D. J. Tindall

4.8k total citations
66 papers, 4.0k citations indexed

About

D. J. Tindall is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, D. J. Tindall has authored 66 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Pulmonary and Respiratory Medicine and 27 papers in Molecular Biology. Recurrent topics in D. J. Tindall's work include Hormonal and reproductive studies (31 papers), Prostate Cancer Treatment and Research (29 papers) and Estrogen and related hormone effects (19 papers). D. J. Tindall is often cited by papers focused on Hormonal and reproductive studies (31 papers), Prostate Cancer Treatment and Research (29 papers) and Estrogen and related hormone effects (19 papers). D. J. Tindall collaborates with scholars based in United States, Sweden and Norway. D. J. Tindall's co-authors include Zheng Fu, Peter E. Lonergan, Matthias Großmann, Hongxia Huang, Charles Y.F. Young, J. E. Perry, Shihadeh N. Nayfeh, Paul E. Andrews, Benjamin T. Montgomery and Anthony R. Means and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

D. J. Tindall

66 papers receiving 3.9k citations

Peers

D. J. Tindall
Evelyn Barrack United States
John M. Kokontis United States
Kin‐Mang Lau Hong Kong
A. E. Wakeling United Kingdom
Susan S. Leong United States
James L. Wittliff United States
James P. Karr United States
Evelyn Barrack United States
D. J. Tindall
Citations per year, relative to D. J. Tindall D. J. Tindall (= 1×) peers Evelyn Barrack

Countries citing papers authored by D. J. Tindall

Since Specialization
Citations

This map shows the geographic impact of D. J. Tindall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. J. Tindall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. J. Tindall more than expected).

Fields of papers citing papers by D. J. Tindall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. J. Tindall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. J. Tindall. The network helps show where D. J. Tindall may publish in the future.

Co-authorship network of co-authors of D. J. Tindall

This figure shows the co-authorship network connecting the top 25 collaborators of D. J. Tindall. A scholar is included among the top collaborators of D. J. Tindall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. J. Tindall. D. J. Tindall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qi, Sathish K.R. Padi, D. J. Tindall, & Bin Guo. (2014). Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31. Cell Death and Disease. 5(10). e1486–e1486. 75 indexed citations
2.
Tindall, D. J. & Peter E. Lonergan. (2011). Androgen receptor signaling in prostate cancer development and progression. Journal of Carcinogenesis. 10(1). 20–20. 399 indexed citations
3.
Dimonte, Guy, Eric J. Bergstralh, Mark E. Bolander, R. Jeffrey Karnes, & D. J. Tindall. (2011). Use of tumor dynamics to clarify the observed variability among biochemical recurrence nomograms for prostate cancer. The Prostate. 72(3). 280–290. 6 indexed citations
4.
Fu, Zheng & D. J. Tindall. (2008). FOXOs, cancer and regulation of apoptosis. Oncogene. 27(16). 2312–2319. 463 indexed citations
5.
Davis, Brittany E., George G. Klee, M.M. Lieber, et al.. (2004). Serum human glandular kallikrein 2 (HK2) concentration at presentation and early subsequent follow-up for patients undergoing primary radiotherapy or brachytherapy with or without androgen deprivation therapy for localized prostate cancer therapy. International Journal of Radiation Oncology*Biology*Physics. 60. S454–S454. 1 indexed citations
6.
Davis, Brian J., George G. Klee, Michael M. Lieber, et al.. (2004). Serum human glandular kallikrein 2 (HK2) concentration at presentation and early subsequent follow-up for patients undergoing primary radiotherapy or brachytherapy with or without androgen deprivation therapy for localized prostate cancer therapy. International Journal of Radiation Oncology*Biology*Physics. 60(1). S454–S454. 1 indexed citations
7.
Huang, Haojie, et al.. (2003). The androgen receptor: a potential target for therapy of prostate cancer. Steroids. 69(2). 79–85. 59 indexed citations
8.
Großmann, Matthias, Hongxia Huang, & D. J. Tindall. (2001). Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer. JNCI Journal of the National Cancer Institute. 93(22). 1687–1697. 437 indexed citations
9.
Spitzweg, Christine, Michael K. O’Connor, Elizabeth R. Bergert, et al.. (2000). Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.. PubMed. 60(22). 6526–30. 180 indexed citations
10.
Black, Margot H., Angeliki Magklara, Christina V. Obiezu, et al.. (2000). Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions. British Journal of Cancer. 82(2). 361–367. 51 indexed citations
11.
Hsieh, Ming-Li, M. Cristine Charlesworth, Marcia K. Goodmanson, et al.. (1997). Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.. PubMed. 57(13). 2651–6. 42 indexed citations
12.
Neubauer, Blake Lee, C. William Hanke, Kenneth S. Hirsch, et al.. (1996). LY191704 inhibits type I steroid 5 alpha-reductase in human scalp.. The Journal of Clinical Endocrinology & Metabolism. 81(6). 2055–2060. 8 indexed citations
13.
Blok, Leen J., Matthias Großmann, J. E. Perry, & D. J. Tindall. (1995). Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation.. Molecular Endocrinology. 9(11). 1610–1620. 90 indexed citations
14.
Andrews, Paul E., Charles Y.F. Young, Benjamin T. Montgomery, & D. J. Tindall. (1992). Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line.. PubMed. 52(6). 1525–9. 43 indexed citations
15.
Young, Charles Y.F., et al.. (1990). Prostatein C3‐mRNA: A sensitive marker of androgen‐responsiveness in prostate explant cultures. The Prostate. 17(1). 41–55. 9 indexed citations
16.
Young, Charles Y.F., James L. Prescott, Michael P. Johnson, et al.. (1988). Monoclonal Antibodies against the Androgen Receptor: Recognition of Human and Other Mammalian Androgen Receptors*. Endocrinology. 123(1). 601–610. 25 indexed citations
17.
Cunningham, Glenn R., et al.. (1983). Characterization of steroid binding specificity of the androgen receptor in human foreskin fibroblasts. Steroids. 41(5). 617–626. 9 indexed citations
18.
Tindall, D. J., Joseph S. Tash, & Anthony R. Means. (1981). Factors affecting Sertoli cell function in the testis.. Environmental Health Perspectives. 38. 5–10. 5 indexed citations
19.
Herbert, Damon C. & D. J. Tindall. (1980). Epididymal Androgen Binding Protein in Protein-Calorie Malnourished Rats. Endocrine Research Communications. 7(1). 61–70. 4 indexed citations
20.
French, Frank S., William S. McLean, Albert A. Smith, et al.. (1974). Androgen Transport and Receptor Mechanisms in Testis and Epididymis. PubMed. 1. 265–285. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026